Inhibikase Therapeutics Inc (FRA:IQT0)
€ 3.21 0 (0%) Market Cap: 5.05 Mil Enterprise Value: -14.25 Mil PE Ratio: 0 PB Ratio: 1.66 GF Score: 41/100